Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This commentary discusses the ICH E14 Q&A(R2) document on thorough QT studies, highlighting areas of ambiguity such as concentration-response modeling, testing in oncology drugs, and combination products.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: